Cargando…

Circulating tumor DNA detection: A potential tool for colorectal cancer management

Colorectal cancer (CRC) is frequently diagnosed at an advanced stage of the disease, the pathogenesis of which is influenced by genetic and epigenetic events. Circulating tumor DNA (ctDNA) is extracellular DNA that is present in a number of bodily fluids, including blood, synovial fluid and cerebros...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Huizi, Jing, Changwen, Wu, Jianzhong, Ni, Jie, Sha, Huanhuan, Xu, Xiaoyue, Du, Yuanyuan, Lou, Rui, Dong, Shuchen, Feng, Jifeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341840/ https://www.ncbi.nlm.nih.gov/pubmed/30675194 http://dx.doi.org/10.3892/ol.2018.9794

Ejemplares similares

MEK inhibitor enhanced the antitumor effect of oxaliplatin and 5-fluorouracil in MEK1 Q56P-mutant colorectal cancer cells
por: Jing, Changwen, et al.
Publicado: (2019)

Liver X receptor agonist T0901317 inhibits the migration and invasion of non-small-cell lung cancer cells in vivo and in vitro
por: Lou, Rui, et al.
Publicado: (2019)

Integrated Analysis of Oncogenic Networks in Colorectal Cancer Identifies GUCA2A as a Molecular Marker
por: Zhang, Hui, et al.
Publicado: (2019)

Cytokine-induced killer cells as a feasible adoptive immunotherapy for the treatment of lung cancer
por: Chen, Dan, et al.
Publicado: (2018)

Circulating tumor DNA in patients with colorectal adenomas: assessment of detectability and genetic heterogeneity
por: Myint, Ni Ni Moe, et al.
Publicado: (2018)

CLASRP oncogene as a novel target for colorectal cancer
por: Gu, Quan, et al.
Publicado: (2023)

Detection of Circulating Tumor DNA Methylation in Diagnosis of Colorectal Cancer
por: Xu, Fei, et al.
Publicado: (2021)

LXR ligands induce apoptosis of EGFR-TKI-resistant human lung cancer cells in vitro by inhibiting Akt-NF-κB activation
por: Liu, Siwen, et al.
Publicado: (2018)

In Vitro and in Vivo Efficacy of NBDHEX on Gefitinib-resistant Human Non-small Cell Lung Cancer
por: Sha, Huanhuan, et al.
Publicado: (2020)

DNA-methylated gene markers for colorectal cancer in TCGA database
por: Zhang, Hui, et al.
Publicado: (2020)

Detection of circulating tumor DNA in patients of operative colorectal and gastric cancers
por: Suzuki, Takeyuki, et al.
Publicado: (2020)

Research Advances in the Role of the Poly ADP Ribose Polymerase Family in Cancer
por: Sha, Huanhuan, et al.
Publicado: (2021)

The Role Of Circulating Tumor DNA In Therapeutic Resistance
por: Xu, Chenxin, et al.
Publicado: (2019)

The somatic mutation landscape of Chinese Colorectal Cancer
por: Ma, Rong, et al.
Publicado: (2020)

Clinical and biological significance of circulating tumor cells, circulating tumor DNA, and exosomes as biomarkers in colorectal cancer
por: Jia, Shiyu, et al.
Publicado: (2017)

Evaluation of Methylation Biomarkers for Detection of Circulating Tumor DNA and Application to Colorectal Cancer
por: Mitchell, Susan M., et al.
Publicado: (2016)

Circulating tumor DNA detectable in early- and late-stage colorectal cancer patients
por: Yang, Ying-Chi, et al.
Publicado: (2018)

Impact of Whole Genome Doubling on Detection of Circulating Tumor DNA in Colorectal Cancer
por: Kabel, Jonas, et al.
Publicado: (2023)

Application of Circulating Tumor DNA as a Non-Invasive Tool for Monitoring the Progression of Colorectal Cancer
por: Zhou, Jiaolin, et al.
Publicado: (2016)

Hypermethylated DNA, a circulating biomarker for colorectal cancer detection
por: Rasmussen, Simon Ladefoged, et al.
Publicado: (2017)

Nedaplatin reduces multidrug resistance of non-small cell lung cancer by downregulating the expression of long non-coding RNA MVIH
por: Jing, Changwen, et al.
Publicado: (2020)

Aldolase A Promotes Colorectal Cancer Progression through Targeting COPS6 and Regulating MAPK Signaling Pathway
por: Lu, Ya, et al.
Publicado: (2023)

Circulating Tumor DNA Detection in the Management of Anti-EGFR Therapy for Advanced Colorectal Cancer
por: Knebel, Franciele H., et al.
Publicado: (2019)

Clinical utility of circulating tumor DNA for colorectal cancer
por: Osumi, Hiroki, et al.
Publicado: (2019)

Liver X receptor agonist T0901317 reverses resistance of A549 human lung cancer cells to EGFR‐TKI treatment
por: Cao, Haixia, et al.
Publicado: (2016)

Liver X receptors agonist GW3965 re-sensitizes gefitinib-resistant human non-small cell lung cancer cell to gefitinib treatment by inhibiting NF-κB in vitro
por: Hu, Yong, et al.
Publicado: (2017)

Detection of an ALK Fusion in Colorectal Carcinoma by Hybrid Capture‐Based Assay of Circulating Tumor DNA
por: Lai, Andrea Z., et al.
Publicado: (2017)

Research Progress on Mono-ADP-Ribosyltransferases in Human Cell Biology
por: Gan, Yujie, et al.
Publicado: (2022)

Circulating tumor DNA detection in lung cancer patients before and after surgery
por: Guo, Nannan, et al.
Publicado: (2016)

Circulating Free DNA as Biomarker and Source for Mutation Detection in Metastatic Colorectal Cancer
por: Spindler, Karen Lise Garm, et al.
Publicado: (2015)

Circulating tumor DNA dynamics and response to immunotherapy in colorectal cancer
por: Gong, Jun, et al.
Publicado: (2022)

The Position of Circulating Tumor DNA in the Clinical Management of Colorectal Cancer
por: de Abreu, Ana Regina, et al.
Publicado: (2023)

Circulating Tumor DNA to Drive Treatment in Metastatic Colorectal Cancer
por: Patelli, Giorgio, et al.
Publicado: (2023)

A feasibility study of colorectal cancer diagnosis via circulating tumor DNA derived CNV detection
por: Molparia, Bhuvan, et al.
Publicado: (2018)

Preoperative detection of KRAS mutated circulating tumor DNA is an independent risk factor for recurrence in colorectal cancer
por: Nakamura, Yuki, et al.
Publicado: (2021)

Circulating Cell Free Tumor DNA Detection as a Routine Tool for Lung Cancer Patient Management
por: Vendrell, Julie A., et al.
Publicado: (2017)

Detection of circulating tumor DNA in patients with osteosarcoma
por: Barris, David M., et al.
Publicado: (2018)

Circulating Tumor DNA as Biomarkers for Cancer Detection
por: Han, Xiao, et al.
Publicado: (2017)

Electrochemical Biosensors for Circulating Tumor DNA Detection
por: Wang, Ke, et al.
Publicado: (2022)

Novel Circulating Tumor Cell Assay for Detection of Colorectal Adenomas and Cancer
por: Tsai, Wen-Sy, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_b2ldik3r2jtuvibmn1cu2beq0h